Rolando Brawer has served as our Chief Business Officer since August 2022. Prior to joining Bruker Cellular Analysis, Dr. Brawer served as Vice President, Science & Technology, Alliances & Ventures at Danaher Corporation where he built a corporate function dedicated to co-founding companies with external inventors, providing capital and expertise to originate early-stage ventures in the life sciences field. Prior to Danaher, he held several positions at life sciences companies including Vice President, Corporate Development, Precision Oncology at Exact Sciences and Vice President, Corporate Development at Genomic Health. He also led Thermo Fisher Scientific’s global strategy for out-licensing and commercial supply for the company’s Life Science Solutions Group. Dr. Brawer started his corporate development career at Invitrogen/Life Technologies. He earned a B.S. and M.S. in Molecular Biology and Biotechnology from the University of Buenos Aires, Ph.D. in Molecular Microbiology from the University of Buenos Aires-Medical School, and M.B.A. from the University of Florida.